くすりのしおり

Injection
Published: 3/2015

The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval details may vary by country. Medicines have adverse reactions (risks) as well as efficacies (benefits). It is important to minimize adverse reactions and maximize efficacy. To obtain a better therapeutic response, patients should understand their medication and cooperate with the treatment.
Brand name :
KANAMYCIN SULFATE INJECTION 1000mg "MEIJI"
 Active ingredient:
Kanamycin sulfate
 Dosage form:
injection
 Print on wrapping:

Effects of this medicine

This medicine is an aminoglycoside antibiotic which inhibits bacterial protein synthesis to exert an antibacterial effect.
It is usually used to treat superficial skin infection, deep skin infection, lymphangitis/lymphadenitis, secondary infection in trauma/burn/surgical wound, mastitis, osteomyelitis, tonsillitis, acute bronchitis, pneumonia, secondary infection in chronic respiratory lesion, cystitis, pyelonephritis, gonococcal infection, uterine adnexitis, otitis media, whooping cough, pulmonary tuberculosis and other tuberculous diseases.

Before using this medicine, be sure to tell your doctor and pharmacist

  • If you have previously experienced any allergic reactions (itch, rash, etc.) to any medicines.
    If you or your family members have deafness due to aminoglycoside antibiotic or deafness due to other causes.
    If you have renal disorder.
    If you have myasthenia gravis.
    If you have poor oral intake or are receiving parenteral nutrition.
    If you are in a poor general condition.
  • If you are pregnant or breastfeeding.
  • If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)

Dosing schedule (How to take this medicine)

  • Your dosing schedule prescribed by your doctor is ((        to be written by a healthcare professional))
  • Pulmonary tuberculosis and other tuberculous diseases: In general, this medicine is injected intramuscularly twice a day twice per week, or once a day three times per week. It is also injected locally as necessary. This medicine, in principle, is used in combination with other antituberculous drugs.
    Other indications: In general, this medicine is injected intramuscularly in one or two divided doses a day.
  • The treatment period with this medicine is determined based on your symptoms.

Precautions while taking this medicine

Possible adverse reactions to this medicine

The most commonly reported adverse reactions include impaired hearing, renal disorder, injection site pain/induration and rash. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
  • tinnitus, deafness, dizziness [VIIIth cranial nerve disorder]
  • decreased urine output, edema, headache [serious renal disorder such as acute renal failure]
  • distressed feeling of chest, respiratory distress, palpitation [shock]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.

Storage conditions and other information

  • If you become unwell during an injection, you should tell your doctor immediately.

For healthcare professional use only : Day Month Year

For further information, talk to your doctor or pharmacist.

Keywords Search

 

 

 

 

Advanced Search

Browse by drug name A-Z
Browse by drug name A-Z